BioCentury

8:00 AM GMT, Feb 6, 2012
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Emerging Company Profile

Nanocytomics: Seeing tiny changes

Lung cancer is one of the deadliest cancers in the U.S. in part because it is often diagnosed too late to be treatable. Nanocytomics LLC thinks its high-resolution imaging technology can cheaply and non-invasively identify patients at high risk of developing lung and other cancers. The company hopes its tests will become standard of care in asymptomatic subjects, akin to Pap smears for cervical cancer.

The company uses partial wave spectroscopy (PWS) microscopy, an optical technique developed by co-founder and CEO Vadim Backman at

Read the full 839 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.